Press Tag: Myonexus

Myonexus Therapeutics Receives FDA Orphan Drug Designation for LGMD Type 2E Treatment
BrinkWire
Myonexus: Race for a Cure Spurs Biotechs to Rely More on Nonprofit Backers
The Wall Street Journal
This Company is the Result of Nationwide Children’s Reviving Gene Therapy in The U.S.
Columbus Business First
Myonexus Therapeutics Secures $2.5M in Seed Financing
finsmes-logo
Nationwide Children’s Gene Therapy Spinout Raises $2.5M to Test Muscular Dystrophy Treatment
Columbus Business First
Myonexus: Term Sheet — Wednesday, December 13
Fortune Term Sheet
Biotech Startup Myonexus Raises Funds for Clinical Trial of Muscular-Dystrophy Gene Therapy
Columbus Dispatch